What SEC filings does Diebold Nixdorf, Incorporated submit to the SEC?

Diebold Nixdorf, Incorporated (DBD) submits several types of SEC filings including Form 4 (insider transactions), Form 144 (proposed insider sales), 8-K reports (material events such as earnings releases, acquisitions, leadership changes), and periodic reports — the 10-Q (quarterly) and 10-K (annual). All filings are publicly available through SEC EDGAR.

What does a Form 4 filing tell me about DBD?

A Form 4 for DBD discloses a transaction by a company insider — typically a director, officer, or 10%+ shareholder. It shows the source-reported date, number of shares, price, and updated ownership. These facts do not establish motive or predict future returns.

How do I interpret an 8-K filing from Diebold Nixdorf, Incorporated?

An 8-K signals a material event requiring prompt disclosure. Common triggers include earnings pre-announcements, acquisitions, leadership appointments or departures, credit changes, or regulatory actions. Read the item codes inside the filing to understand exactly what was disclosed before drawing conclusions.

What is the difference between a 10-K and 10-Q for DBD?

The 10-K is Diebold Nixdorf, Incorporated's annual report with fully audited financial statements, comprehensive MD&A, and complete risk factor disclosures — filed 60–90 days after fiscal year-end. The 10-Q is a lighter quarterly report with unaudited financials filed for the first three quarters. Together they provide a continuous financial picture of the company.

Where can I see all DBD SEC filings directly on EDGAR?

You can view all historical Diebold Nixdorf, Incorporated filings on the SEC EDGAR company page for DBD. Each filing card on this page links directly to the original SEC document.

How often does Diebold Nixdorf, Incorporated file with the SEC?

Diebold Nixdorf, Incorporated files one 10-K per year and up to three 10-Qs per year. Form 4 insider transactions must be reported within two business days of each trade, so the frequency depends on how often insiders are buying or selling DBD shares. 8-K filings occur whenever a material event happens — which can be several times per quarter for an active company.

DBD SEC Filing News — Diebold Nixdorf, Incorporated

Latest SEC filings for Diebold Nixdorf, Incorporated (DBD) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-07-31.

Diebold Nixdorf, Incorporated engages in the automating, digitizing, and transforming the way people bank and shop worldwide. It operates through two segments, Banking and Retail. The company offers automated teller machines, cash recyclers, dispensers, teller automation tools, and kiosk technologies. The Banking segment manufactures and sells branch automation solutions, including DN Series recyclers, ATMs, cash recycling technology, and the DN Teller Cash Recycler and Dual Tower Recycler, as w…

Sector: Technology Industry: Software - Application Market Cap: $2.3B CIK: 28823

Total Filings

Bullish Classifications

Bearish Classifications

Insider Transactions

Material Events (8-K)

Periodic Reports

Rule-based classifications for DBD currently lean bearish. Of the 20 filing records displayed, 7 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 4 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.

DBD Filing Activity Snapshot 2026-04-10 — 2026-07-31

Insider Transactions (Form 4)

4 buys vs 7 sells

Net insider selling in this period — insiders sell for many reasons beyond conviction.

Largest Form 144 Filing

$32.96M

Millstreet Capital Management LLC (10% Owner) · 2026-04-10

399,929 shares · Form 4

Insider Transactions 15 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 15 filings in this group are Form 4s for Diebold Nixdorf, Incorporated.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 15 insider filings shown, the breakdown is 7 open-market sale, 4 open-market purchase, 3 compensation award and 1 gift. 11 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×7: The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Open-market purchase ×4: The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.
Compensation award ×3: Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Gift ×1: Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Form 4 Open-market purchase Insider Buying 2026-07-31

DBD insider Timko Thomas S (EVP, CFO) bought 700 shares (~$50.6K)

Timko Thomas S, listed as EVP, CFO at DIEBOLD NIXDORF, Inc, reported an open-market purchase of 700 DBD shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	700	$72.29	$50.6K

Filing: Form 4 (Insider Transaction) Insider: Timko Thomas S (EVP, CFO) Shares: 700 Est. Value: $50.6K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-30

DBD insider Millstreet Capital Management LLC (10% Owner) sold 100,000 shares (~$8.48M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 100,000 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	100,000	$84.80	$8.48M

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 100,000 Est. Value: $8.48M

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-26

DBD insider Millstreet Capital Management LLC (10% Owner) sold 231,464 shares (~$19.43M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 231,464 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	228,723	$83.95	$19.20M
`S`	Open-market sale	2,741	$85.06	$233.1K

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 231,464 Est. Value: $19.43M

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-16

DBD insider Millstreet Capital Management LLC (10% Owner) sold 161,440 shares (~$13.26M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 161,440 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	159,675	$82.12	$13.11M
`S`	Open-market sale	1,765	$83.91	$148.1K

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 161,440 Est. Value: $13.26M

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-12

DBD insider Millstreet Capital Management LLC (10% Owner) sold 18,768 shares (~$1.54M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 18,768 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	17,660	$82.08	$1.45M
`S`	Open-market sale	1,108	$82.06	$90.9K

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 18,768 Est. Value: $1.54M

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-06-10

DBD insider Millstreet Capital Management LLC (10% Owner) sold 88,334 shares (~$7.33M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 88,334 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	88,334	$82.99	$7.33M

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 88,334 Est. Value: $7.33M

View on SEC EDGAR → Open Filing Document →

Form 4 Gift Tax / Compensation Filing 2026-06-04

DBD insider Form 4 filed for equity award, exercise, or tax withholding

Timko Thomas S (EVP, CFO) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were transferred as a gift, typically for estate or charitable planning. No sale into the market took place.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`G`	Gift	672	—	—
`G`	Gift	672	—	—

Filing: Form 4 (Insider Transaction) Insider: Timko Thomas S (EVP, CFO) Shares: 1,344

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-05-27

DBD insider Marquez Octavio (Director, President and CEO) bought 1,250 shares (~$99.3K)

Marquez Octavio, listed as Director, President and CEO at DIEBOLD NIXDORF, Inc, reported an open-market purchase of 1,250 DBD shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	629	$79.37	$49.9K
`P`	Open-market purchase	621	$79.56	$49.4K

Filing: Form 4 (Insider Transaction) Insider: Marquez Octavio (Director, President and CEO) Shares: 1,250 Est. Value: $99.3K

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-05-22

DBD insider Timko Thomas S (EVP, CFO) bought 672 shares (~$50.0K)

Timko Thomas S, listed as EVP, CFO at DIEBOLD NIXDORF, Inc, reported an open-market purchase of 672 DBD shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	672	$74.36	$50.0K

Filing: Form 4 (Insider Transaction) Insider: Timko Thomas S (EVP, CFO) Shares: 672 Est. Value: $50.0K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-05-22

DBD insider Form 4 filed for equity award, exercise, or tax withholding

Parris Colin J. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	2,621	—	—

Filing: Form 4 (Insider Transaction) Insider: Parris Colin J. (Director) Shares: 2,621

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market purchase Insider Buying 2026-05-22

DBD insider Myers Jonathan (EVP, Chief Revenue Officer) bought 1,360 shares (~$99.8K)

Myers Jonathan, listed as EVP, Chief Revenue Officer at DIEBOLD NIXDORF, Inc, reported an open-market purchase of 1,360 DBD shares in a Form 4 filing. Insider buying is often treated as a bullish signal because company insiders are committing their own capital.

The insider bought shares on the open market with their own money. This is the only Form 4 category that requires a discretionary cash outlay at the prevailing price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`P`	Open-market purchase	1,360	$73.41	$99.8K

Filing: Form 4 (Insider Transaction) Insider: Myers Jonathan (EVP, Chief Revenue Officer) Shares: 1,360 Est. Value: $99.8K

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-05-22

DBD insider Form 4 filed for equity award, exercise, or tax withholding

Markus Maura A. (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	2,621	—	—

Filing: Form 4 (Insider Transaction) Insider: Markus Maura A. (Director) Shares: 2,621

View on SEC EDGAR → Open Filing Document →

Form 4 Compensation award Tax / Compensation Filing 2026-05-13

DBD insider Form 4 filed for equity award, exercise, or tax withholding

Singh Rajesh K (EVP, Chief Information Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`A`	Compensation award	17,128	—	—

Filing: Form 4 (Insider Transaction) Insider: Singh Rajesh K (EVP, Chief Information Officer) Shares: 17,128

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-04-17

DBD insider Millstreet Capital Management LLC (10% Owner) sold 112,305 shares (~$9.55M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 112,305 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	51,472	$85.43	$4.40M
`S`	Open-market sale	60,833	$84.77	$5.16M

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 112,305 Est. Value: $9.55M

View on SEC EDGAR → Open Filing Document →

Form 4 Open-market sale Insider Selling 2026-04-10

DBD insider Millstreet Capital Management LLC (10% Owner) sold 399,929 shares (~$32.96M)

Millstreet Capital Management LLC, listed as 10% Owner at DIEBOLD NIXDORF, Inc, reported an open-market sale of 399,929 DBD shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code	Nature	Shares	Price	Value
`S`	Open-market sale	399,929	$82.42	$32.96M

Filing: Form 4 (Insider Transaction) Insider: Millstreet Capital Management LLC (10% Owner) Shares: 399,929 Est. Value: $32.96M

View on SEC EDGAR → Open Filing Document →

Material Events 3 · Form 8-K

An 8-K reports a material event in the window between scheduled reports. There are 3 in this period for Diebold Nixdorf, Incorporated. Each 8-K names the item number it is filed under, and that number is the fastest way to tell a routine disclosure from a consequential one.

Item 2.02 is an earnings release, Item 5.02 is a change of directors or officers, and Item 1.01 or 2.01 covers a material agreement or a completed acquisition. Item 7.01 and Item 8.01 are the general-purpose disclosure items and carry no fixed meaning on their own.

Form 8-K Material Company Update 2026-07-29

DBD filed 8-K — material company event

DIEBOLD NIXDORF, Inc filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-05-26

DBD filed 8-K — material company event

DIEBOLD NIXDORF, Inc filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Form 8-K Material Company Update 2026-04-30

DBD filed 8-K — material company event

DIEBOLD NIXDORF, Inc filed an 8-K with the SEC reporting a material event. Summary unavailable — view the original SEC filing for the full text.

Filing: 8-K (Material Event)

View on SEC EDGAR → Open Filing Document →

Periodic Reports 2 · Forms 10-K and 10-Q

The periodic reports are where the audited and reviewed financial statements live. This period contains 2 quarterly reports (10-Q) for Diebold Nixdorf, Incorporated.

The two are not equivalent in weight. A 10-K is audited by an external firm and includes the full risk factor disclosure, business description and management discussion; a 10-Q is unaudited, reviewed rather than examined, and much shorter. When a figure in a quarterly report is later revised, the annual report is usually where the correction appears.

An amended report — 10-K/A or 10-Q/A — restates or corrects something in the original filing, and is worth reading against the version it replaces.

Form 10-Q Quarterly Report 2026-07-29

DBD filed Quarterly Report (10-Q)

DIEBOLD NIXDORF, Inc filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

View on SEC EDGAR → Open Filing Document →

Form 10-Q Quarterly Report 2026-04-30

DBD filed Quarterly Report (10-Q)

DIEBOLD NIXDORF, Inc filed its quarterly report with the SEC. This report includes unaudited financial statements and management discussion for the quarter.

Filing: 10-Q (Quarterly Report)

View on SEC EDGAR → Open Filing Document →

How we classify Diebold Nixdorf, Incorporated's filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on DBD. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — DBD SEC Filings

More Tools for DBD

DBD Full Stock Analysis DBD Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper DBD analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the DBD stock analysis page.

DBD Full Analysis

Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.

Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer